Brief: Hofseth Biocare Saw Solid Demand Growth In Ingredients Biz In Q1
May 16 (Reuters) - Hofseth Biocare ASA HBC.OL :
* UNDERLYING GROWTH WE ARE SEEING IS COMING FROM BOTH INGREDIENTS BUSINESS AND FINISHED
PRODUCTS
CHANNELS
* INGREDIENTS BUSINESS CONTINUES TO HAVE SOLID DEMAND GROWTH
* WE HAVE SEEN INCREASED DEMAND FOR OUR PREMIUM PURE SPH PRODUCT WITHIN THIS SEGMENT
Source text for Eikon: ID:nGNE81Nshw
Further company coverage: HBC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hofseth Biocare ASA
See all newsBrief: Hofseth BioCare Board Member Buys 2.5 Mln Shares in Company
Brief: Hofseth Biocare Appoints Leif Arne Giske As CFO
Hofseth BioCare Q2 operating revenue slips on lower raw material volumes
Brief: Hofseth Biocare Q2 Revenue NOK 65.7 Million
Brief: Research Corporation Buys 14.3 Mln Shares In Hofseth Biocare